Metabolic syndrome and hormone profile in patients with erectile dysfunction

Arrabal-Polo, Miguel Ángel; Arias‐Santiago, Salvador; López-Carmona, F.; Merino‐Salas, Sergio; Lahoz-Garcia, C.; Zuluaga-Gomez, Armando; Arrabal‐Martín, Miguel

doi:10.1016/j.acuroe.2012.07.003

Cited by 5 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is interesting to note that duration and severity of ED have been observed to correlate with glycemic control [77]. The determination of glycemia and the total amount of fatty substances (cholesterol and TGs) in the blood are required for the initial metabolic evaluation of the patients (Table ) [33,42,78,79].…”

Section: Assessment Of Ed In Patients With Metsmentioning

confidence: 99%

A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction

Kaya

Sikka

Gür

2015

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Metabolic syndrome (MetS) is the most important public health issue threatening the health of men and women all over the world. Its current prevalence (i.e., approximately 30%) is continuously increasing. MetS by itself is considered a risk factor for erectile dysfunction (ED). Aim To focus on the definition epidemiology, pathogenesis, and possible mechanistic links between MetS and ED in order to provide guidelines for treating such individuals. Methods The search strategies yielded total records screened from PubMed. Main Outcome Measures Regardless of the definition, MetS consists of insulin resistance, hypertension, dyslipidemia, and obesity. MetS is not an end disease but is a disorder of energy utilization and storage. Results The prevalence of ED in patients with MetS is almost twice than in those without MetS, and about 40% of patients with ED have MetS. An important mechanism linking MetS and ED is hypogonadism. Conclusions Recognizing through ED, underlying conditions such as hypogonadism, diabetes and MetS might be a useful motivation for men to improve their health-related choices. The clinical management of MetS can be done by therapeutic interventions that include lifestyle modifications, hormone replacement alone or in combination with phosphodiesterase 5 inhibitors, and other pharmacological treatments.

show abstract

Section: Assessment Of Ed In Patients With Metsmentioning

confidence: 99%